PARD - Poniard Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
Total Revenue
0
Cost of Revenue
0
Gross Profit
0
Operating Expense
15,533
Operating Income
-15,533
Net Non Operating Interest Income Expense
-509
Net Income Common Stockholders
-16,234
Diluted NI Available to Com Stockholders
-16,234
Total Operating Income as Reported
-15,533
Total Expenses
15,533
Net Income from Continuing & Discontinued Operation
-16,042
Normalized Income
-16,042
Interest Income
27
Interest Expense
536
Net Interest Income
-509
EBIT
-15,533
EBITDA
-14,258
Reconciled Cost of Revenue
0
Reconciled Depreciation
1,275
Net Income from Continuing Operation Net Minority Interest
-16,042
Total Unusual Items Excluding Goodwill
0
Total Unusual Items
0
Normalized EBITDA
-14,258
Tax Rate for Calcs
0
Tax Effect of Unusual Items
0